TFSA Investors: 3 Pointers From Legendary Warren Buffett

Warren Buffett takes a methodical approach to investing that TFSA investors should take heed of.

close-up photo of investor Warren Buffett

Image source: The Motley Fool

When it comes to the investing world, very few people have the aptitude of Warren Buffett. Based on a principle known as value investing, Warren Buffett’s strategy is to find undervalued companies in industries he understands that he intends on buying and holding indefinitely.

At the centre of Warren Buffett’s approach are three main philosophies that I will share with you.

Understand the businesses you invest in

Warren Buffett has been quoted saying, “Never invest in a business you cannot understand.” The crux of this argument lies in the fact that investors are able to make better decisions in industries they know well.

Warren Buffett himself practices what he preaches with his company, Berkshire Hathaway, owning companies such as Dairy Queen and Fruit of the Loom. Dairy Queen is a fast-food restaurant that specializes in hamburgers and ice cream. Fruit of the Loom is an American company that manufactures clothing, with a focus on underwear and sports equipment.

In terms of Canadian stocks, Warren Buffett would be interested in the likes of Sleep Country, which engages in the retail and online sales of mattresses. Sleep Country owns Endy, an online mattress-in-a-box company. Based on my calculations using a discounted cash flow model, I determined Sleep Country has an intrinsic value of $24.23 per share, which is a premium to the $20.49 at the time of writing.

Plan to buy and hold stocks forever

When it comes to the time horizon for investing, Warren Buffett makes a good point. “If you aren’t thinking about owning a stock for 10 years, don’t even think about owning it for 10 minutes.”

The main point of this argument centres on discipline. The best investors are usually the most patient and can invest without emotion. I remember reading an article on Warren Buffett whereby he mentioned the best way to approach investing is to analyze a company as if you were to buy it. If the company is not attractive enough to buy, then it is not attractive enough to invest.

Using this approach, I am bullish on Fire & Flower. The company engages in the retail sale of marijuana and marijuana related products. It is backed by an investment from Couche-Tard of $26 million for a 9.9% stake in the company. This gives it an implicit value of $2.16 per share.

Price and value are not the same

This is arguably the most important distinction to make when it comes to investing. Warren Buffett makes a very good point about price and value. “Price is what you pay. Value is what you get.”

I couldn’t have said it better myself. This is one of the key philosophies behind intrinsic value for value investors. By using valuation methods such as discounted cash flow, comparable company analysis, and precedent company analysis, investors can determine the present value of a business.

I am a proponent of value investing, and through this method, I calculated that Recipe Unlimited is currently undervalued. With an intrinsic value of $97.83 compared to the price at writing of $18.83, Recipe Unlimited has the potential to deliver significant returns to its investors. The company was formerly called Cara Operations, and its brands include The Keg, Milestones, and Bier Markt to list but a few.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chen Liu owns shares of FAF. The Motley Fool owns shares of and recommends Berkshire Hathaway (B shares). The Motley Fool recommends ALIMENTATION COUCHE-TARD INC and recommends the following options: long January 2021 $200 calls on Berkshire Hathaway (B shares), short January 2021 $200 puts on Berkshire Hathaway (B shares), and short March 2020 $225 calls on Berkshire Hathaway (B shares).

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »